156K cancer patients could miss out on life-saving drugs every year in US and Europe

May 18th, 2017



Irish medtech company Diaceutics has announced research results showing that more than 156,000 cancer patients in the US and Europe could be missing out on targeted life-saving drugs every year due to suboptimal diagnostic testing – therefore potentially affecting their chances of survival.

Latest Blogs

View all